Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 264

1.

Mycobacterium tuberculosis in solid organ transplantation: incidence before and after expanded isoniazid prophylaxis.

Al-Mukhaini SM, Al-Eid H, Alduraibi F, Hakami HI, Talhi HA, Shoukri M, Ahmed AM, Ahmed Y, Alrajhi AA.

Ann Saudi Med. 2017 Mar-Apr;37(2):138-143. doi: 10.5144/0256-4947.2017.138.

2.

Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis.

Adamu B, Abdu A, Abba AA, Borodo MM, Tleyjeh IM.

Cochrane Database Syst Rev. 2014 Mar 4;(3):CD008597. doi: 10.1002/14651858.CD008597.pub2. Review.

PMID:
24590589
3.

Tuberculosis in renal transplant recipients: the evidence for prophylaxis.

Currie AC, Knight SR, Morris PJ.

Transplantation. 2010 Oct 15;90(7):695-704. doi: 10.1097/TP.0b013e3181ecea8d. Review.

PMID:
20647975
4.

Outcome of latent tuberculosis infection in solid organ transplant recipients over a 10-year period.

Sidhu A, Verma G, Humar A, Kumar D.

Transplantation. 2014 Sep 27;98(6):671-5. doi: 10.1097/TP.0000000000000133.

PMID:
24825525
5.
6.

Liver transplantation without isoniazid prophylaxis for recipients with a history of tuberculosis.

Nagai S, Fujimoto Y, Taira K, Egawa H, Takada Y, Kiuchi T, Tanaka K.

Clin Transplant. 2007 Mar-Apr;21(2):229-34.

PMID:
17425750
7.

Clinical features and outcomes of tuberculosis in solid organ transplant recipients.

Bodro M, Sabé N, Santín M, Cruzado JM, Lladó L, González-Costello J, Carratalà J.

Transplant Proc. 2012 Nov;44(9):2686-9. doi: 10.1016/j.transproceed.2012.09.060.

PMID:
23146494
8.

Mycobacterium tuberculosis infection in solid organ transplant recipients: experience from a single center in China.

Zhang XF, Lv Y, Xue WJ, Wang B, Liu C, Tian PX, Yu L, Chen XY, Liu XM.

Transplant Proc. 2008 Jun;40(5):1382-5. doi: 10.1016/j.transproceed.2008.01.075.

PMID:
18589112
9.

Tuberculosis following solid organ transplantation.

Lopez de Castilla D, Schluger NW.

Transpl Infect Dis. 2010 Apr;12(2):106-12. doi: 10.1111/j.1399-3062.2009.00475.x. Epub 2009 Dec 9.

PMID:
20002613
10.

The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants.

Minari A, Husni R, Avery RK, Longworth DL, DeCamp M, Bertin M, Schilz R, Smedira N, Haug MT, Mehta A, Gordon SM.

Transpl Infect Dis. 2002 Dec;4(4):195-200.

PMID:
12535262
11.

Anti-tuberculosis prophylaxis following renal transplantation: acceptable variations?

Field M, Clarke A, Kelleher M, Hamsho A, Mellor S, Ready A, Inston N, van Dellen D.

Transpl Infect Dis. 2012 Oct;14(5):551-4. doi: 10.1111/j.1399-3062.2012.00717.x. Epub 2012 Feb 9.

PMID:
22321406
12.

Mycobacterium tuberculosis infections after renal transplantation.

Apaydin S, Altiparmak MR, Serdengeçti K, Ataman R, Oztürk R, Erek E.

Scand J Infect Dis. 2000;32(5):501-5.

PMID:
11055654
13.

Clinical features and outcome of tuberculosis in solid organ transplant recipients.

Hsu MS, Wang JL, Ko WJ, Lee PH, Chou NK, Wang SS, Chu SH, Chang SC.

Am J Med Sci. 2007 Aug;334(2):106-10.

PMID:
17700199
14.

Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA.

Aguado JM, Herrero JA, Gavaldá J, Torre-Cisneros J, Blanes M, Rufí G, Moreno A, Gurguí M, Hayek M, Lumbreras C, Cantarell C.

Transplantation. 1997 May 15;63(9):1278-86. Review. Erratum in: Transplantation 1997 Sep 27;64(6):942.

PMID:
9158022
15.

Isoniazid treatment to prevent TB in kidney and pancreas transplant recipients based on an interferon-γ-releasing assay: an exploratory randomized controlled trial.

Kim SH, Lee SO, Park IA, Kim SM, Park SJ, Yun SC, Jung JH, Shin S, Kim YH, Choi SH, Kim YS, Woo JH, Park SK, Park JS, Han DJ.

J Antimicrob Chemother. 2015 May;70(5):1567-72. doi: 10.1093/jac/dku562. Epub 2015 Jan 20.

PMID:
25608587
16.

Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area.

Cuellar-Rodriguez J, Avery RK, Lard M, Budev M, Gordon SM, Shrestha NK, van Duin D, Oethinger M, Mawhorter SD.

Clin Infect Dis. 2009 Sep 1;49(5):710-6. doi: 10.1086/604712.

PMID:
19635026
17.

Tuberculosis prophylaxis with levofloxacin in liver transplant patients is associated with a high incidence of tenosynovitis: safety analysis of a multicenter randomized trial.

Torre-Cisneros J, San-Juan R, Rosso-Fernández CM, Silva JT, Muñoz-Sanz A, Muñoz P, Miguez E, Martín-Dávila P, López-Ruz MA, Vidal E, Cordero E, Montejo M, Blanes M, Fariñas MC, Herrero JI, Rodrigo J, Aguado JM.

Clin Infect Dis. 2015 Jun 1;60(11):1642-9. doi: 10.1093/cid/civ156. Epub 2015 Feb 25.

PMID:
25722196
18.

Spectrum of cancer risk among US solid organ transplant recipients.

Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, Copeland G, Finch JL, Fleissner ML, Goodman MT, Kahn A, Koch L, Lynch CF, Madeleine MM, Pawlish K, Rao C, Williams MA, Castenson D, Curry M, Parsons R, Fant G, Lin M.

JAMA. 2011 Nov 2;306(17):1891-901. doi: 10.1001/jama.2011.1592.

19.

Role of isoniazid prophylaxis for prevention of tuberculosis in haemopoietic stem cell transplant recipients.

Ahmed P, Anwar M, Khan B, Altaf C, Ullah K, Raza S, Hussain I.

J Pak Med Assoc. 2005 Sep;55(9):378-81.

20.

The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study.

Assebe LF, Reda HL, Wubeneh AD, Lerebo WT, Lambert SM.

BMC Public Health. 2015 Apr 10;15:346. doi: 10.1186/s12889-015-1719-0.

Supplemental Content

Support Center